nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A metabolic switch to memory CAR T cells: Implications for cancer treatment
|
Rostamian, Hosein |
|
|
500 |
C |
p. 107-118 |
artikel |
2 |
A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening
|
Zhang, Liyang |
|
|
500 |
C |
p. 87-97 |
artikel |
3 |
Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes
|
Mavingire, Nicole |
|
|
500 |
C |
p. 64-74 |
artikel |
4 |
Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation
|
Wang, Lixia |
|
|
500 |
C |
p. 172-181 |
artikel |
5 |
Corrigendum to “Impact of SCID mouse gender on tumorigenicity, xenograft growth and drug-response in a large panel of orthotopic PDX models of pediatric brain tumors” [Cancer Lett. 493 (2020) 197–206]
|
Qi, Lin |
|
|
500 |
C |
p. 294 |
artikel |
6 |
Corrigendum to “Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.” [Canc. Lett. 449 (2019) 31–44]
|
Xie, Ruihui |
|
|
500 |
C |
p. 292-293 |
artikel |
7 |
Editorial Board
|
|
|
|
500 |
C |
p. ii |
artikel |
8 |
eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis
|
Ma, Shijie |
|
|
500 |
C |
p. 11-20 |
artikel |
9 |
Exosomal O-GlcNAc transferase from esophageal carcinoma stem cell promotes cancer immunosuppression through up-regulation of PD-1 in CD8+ T cells
|
Yuan, Yunfeng |
|
|
500 |
C |
p. 98-106 |
artikel |
10 |
Featuring the guest editor for three Special Issues
|
Jiang, Shuai |
|
|
500 |
C |
p. 271 |
artikel |
11 |
Fucoidan-coated nanoparticles target radiation-induced P-selectin to enhance chemoradiotherapy in murine colorectal cancer
|
DuRoss, Allison N. |
|
|
500 |
C |
p. 208-219 |
artikel |
12 |
Functional long non-coding RNAs in hepatocellular carcinoma
|
Xie, Chen |
|
|
500 |
C |
p. 281-291 |
artikel |
13 |
Galactosyltransferase B4GALT1 confers chemoresistance in pancreatic ductal adenocarcinomas by upregulating N-linked glycosylation of CDK11p110
|
Chen, Yitian |
|
|
500 |
C |
p. 228-243 |
artikel |
14 |
Helper T cells in malignant pleural effusion
|
Yi, Feng-Shuang |
|
|
500 |
C |
p. 21-28 |
artikel |
15 |
Hsp90 inhibitor-loaded IR780 micelles for mitochondria-targeted mild-temperature photothermal therapy in xenograft models of human breast cancer
|
Zhang, Tao |
|
|
500 |
C |
p. 41-50 |
artikel |
16 |
IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway
|
Sun, Longhao |
|
|
500 |
C |
p. 132-146 |
artikel |
17 |
Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs
|
Chen, Chenglong |
|
|
500 |
C |
p. 1-10 |
artikel |
18 |
Inhibition of glycolytic activator PFKFB3 suppresses tumor growth and induces tumor vessel normalization in hepatocellular carcinoma
|
Matsumoto, Kenichi |
|
|
500 |
C |
p. 29-40 |
artikel |
19 |
Interaction of Nrf2 with dimeric STAT3 induces IL-23 expression: Implications for breast cancer progression
|
Kim, Su-Jung |
|
|
500 |
C |
p. 147-160 |
artikel |
20 |
Long non-coding RNAs: Emerging regulators for chemo/immunotherapy resistance in cancer stem cells
|
Shen, Chongyang |
|
|
500 |
C |
p. 244-252 |
artikel |
21 |
Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer
|
Zhou, Li |
|
|
500 |
C |
p. 163-171 |
artikel |
22 |
Recent progress of metabolic enzymes research in cancer
|
Jiang, Shuai |
|
|
500 |
C |
p. 272-273 |
artikel |
23 |
Reduced RBX1 expression induces chromosome instability and promotes cellular transformation in high-grade serous ovarian cancer precursor cells
|
Bungsy, Manisha |
|
|
500 |
C |
p. 194-207 |
artikel |
24 |
Response to the Letter to the editor regarding “Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma” by Jiong Lin
|
Santofimia-Castaño, Patricia |
|
|
500 |
C |
p. 161-162 |
artikel |
25 |
sORF-Encoded MicroPeptides: New players in inflammation, metabolism, and precision medicine
|
Chen, Ying |
|
|
500 |
C |
p. 263-270 |
artikel |
26 |
Targeted delivery of small noncoding RNA for glioblastoma
|
Yoo, Ji Young |
|
|
500 |
C |
p. 274-280 |
artikel |
27 |
Targeting NPM1 in irradiated cells inhibits NPM1 binding to RAD51, RAD51 foci formation and radiosensitizes NSCLC
|
Traver, Geri |
|
|
500 |
C |
p. 220-227 |
artikel |
28 |
The double-edged sword of H19 lncRNA: Insights into cancer therapy
|
Shermane Lim, Yun Wei |
|
|
500 |
C |
p. 253-262 |
artikel |
29 |
The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment
|
Hayes, Conall |
|
|
500 |
C |
p. 75-86 |
artikel |
30 |
Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma
|
Casagrande, Naike |
|
|
500 |
C |
p. 182-193 |
artikel |
31 |
Voltage-gated sodium channel Nav1.5 promotes tumor progression and enhances chemosensitivity to 5-fluorouracil in colorectal cancer
|
Sui, Qiaoqi |
|
|
500 |
C |
p. 119-131 |
artikel |
32 |
YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer
|
Lo Sardo, Federica |
|
|
500 |
C |
p. 51-63 |
artikel |